NICE IMMUNO-ONCOLOGY APPRAISALS: COMPARISON OF PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL ANALYSIS METHODS AND CRITIQUE

被引：0
|
作者：
Chalmers, K. [1 ]
Pagotto, A. [1 ]
Langford, B. [1 ]
Diamantopoulos, A. [1 ]
Rinciog, C. [1 ]
机构：
[1] Symmetron Ltd, London, England
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA245
引用
收藏
页码：S344 / S344
页数：1
相关论文
共 50 条
  • [41] Meta-analysis of the association between progression-free survival and overall survival in metastatic colorectal cancer
    Costel Chirila
    Dawn Odom
    Giovanna Devercelli
    Shahnaz Khan
    Bintu N. Sherif
    James A. Kaye
    István Molnár
    Beth Sherrill
    [J]. International Journal of Colorectal Disease, 2012, 27 : 623 - 634
  • [42] Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma
    Han, Kelong
    Ren, Melanie
    Wick, Wolfgang
    Abrey, Lauren
    Das, Asha
    Jin, Jin
    Reardon, David A.
    [J]. NEURO-ONCOLOGY, 2015, 17 (05) : 764 - 765
  • [43] Analysis of progression-free survival in oncology trials: Some common statistical issues
    Carroll, Kevin J.
    [J]. PHARMACEUTICAL STATISTICS, 2007, 6 (02) : 99 - 113
  • [44] CHALLENGES AND METHODOLOGIES IN USING PROGRESSION FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN ONCOLOGY
    Hernandez-Villafuerte, Karla
    Fischer, Alastair
    Latimer, Nicholas
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2018, 34 (03) : 300 - 316
  • [45] Missing Data and Censoring in the Analysis of Progression-Free Survival in Oncology Clinical Trials
    Denne, J. S.
    Stone, A. M.
    Bailey-Iacona, R.
    Chen, T. -T.
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2013, 23 (05) : 951 - 970
  • [46] IS PROGRESSION-FREE SURVIVAL A GOOD INDICATOR OF OVERALL SURVIVAL FOR PAZOPANIB IN PATIENTS WITH SYNOVIAL SARCOMA?
    Han, J.
    Lee, S.
    Cho, E.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S489 - S490
  • [47] Combining progression-free survival and overall survival as a novel composite endpoint for glioblastoma trials
    Trippa, Lorenzo
    Wen, Patrick Y.
    Parmigiani, Giovanni
    Berry, Donald A.
    Alexander, Brian M.
    [J]. NEURO-ONCOLOGY, 2015, 17 (08) : 1106 - 1113
  • [48] Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer
    Cicero, Giuseppe
    De Luca, Rossella
    Dieli, Francesco
    [J]. ONCOTARGETS AND THERAPY, 2018, 11 : 3059 - 3063
  • [49] Overall Survival and Progression-Free Survival of Patients Following Luspatercept Treatment in the MEDALIST Trial
    Santini, Valeria
    Fenaux, Pierre
    Zeidan, Amer M.
    Komrokji, Rami S.
    Buckstein, Rena
    Oliva, Esther Natalie
    Ha, Xianwei
    Miteva, Dimana
    Yucel, Aylin
    Nadal, Jose Alberto
    Platzbecker, Uwe
    [J]. BLOOD, 2022, 140 : 4079 - 4081
  • [50] Progression-Free Survival Versus Overall Survival in Ovarian Cancer: Where Are We Now?
    Susana Banerjee
    Stan Kaye
    [J]. Current Oncology Reports, 2012, 14 : 483 - 485
12345